Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.

@article{Deo2013PredictiveVO,
  title={Predictive value of the model for end-stage liver disease score in patients undergoing left ventricular assist device implantation.},
  author={Salil V. Deo and Richard Daly and Salah Eldien I Altarabsheh and Tal Hasin and Yanjun Zhao and Ishan K Shah and John M. Stulak and Barry Anthony Boilson and John A. Schirger and Lyle D. Joyce and Soon Joo Park},
  journal={ASAIO journal},
  year={2013},
  volume={59 1},
  pages={57-62}
}
Axial flow left ventricular assist device (LVAD) implantation is an effective therapy for patients with advanced heart failure. As the preoperative hepatic and renal function play a critical role in determining adverse events after LVAD implantation, we analyzed the predictive role of the model for end-stage liver disease (MELD) score in determining in… CONTINUE READING